Longeveron Mesenchymal Stem Cells (LMSCs)

Phase 2Completed
0 watching 0 views this week Active
44
Hype Score

Development Stage

Pre-clinical
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Aging Frailty

Conditions

Aging Frailty

Trial Timeline

Jul 6, 2017 → Sep 30, 2021

About Longeveron Mesenchymal Stem Cells (LMSCs)

Longeveron Mesenchymal Stem Cells (LMSCs) is a phase 2 stage product being developed by Longeveron for Aging Frailty. The current trial status is completed. This product is registered under clinical trial identifier NCT03169231. Target conditions include Aging Frailty.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (2)

NCT IDPhaseStatus
NCT04629105Phase 1UNKNOWN
NCT03169231Phase 2Completed